Wayne F Beyer

This inventor holds 34 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 6 EPO patents, primarily in Energy Augmentation Structures. Top assignees: Immunolight, LLC, Duke University, Affinergy Inc.. Active years: 1993-2024.

USPTO Granted Patents = 34 (Patent Applications = 4)

% Patents Active = 67.6

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 6 (Patent Applications = 13)

Average Co-Inventor Count = 5.0

ph-index = 7

Forward Citations = 756(Granted Patents)

Location History:

Bahama, NC (US) (1993 - 2023)
Detroit, MI (US) (2024)

Company Filing History:

Becton Dickinson and Company Limited

patents

5. 1 out of 3,519

University of Michigan

patents

6. 4 out of 834,350

Other

patents

where one patent can have more than one assignee

Years Active: 1993-2024

Loading Chart...

Areas of Expertise:

Energy Augmentation

X-ray Therapy

Cancer Treatment

Phosphor Activators

Adhesive Bonding

Solar Cells

Isothermal Amplification

Mycobacteriophage

Tumor Imaging

Orthopedic Implants

Photo-reactive Species

Superoxide Dismutase

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12121746 - Energy augmentation structures, energy emitters or energy collectors containing the same, and their use in methods and systems for treating cell proliferation disorders (2024-10-22),

2. 12076579 - Energy augmentation structures in adhesive bonding compositions (2024-09-03),

3. 11998760 - Energy augmentation structures and their use in solar cells and other energy conversion devices (2024-06-04),

4. 11964167 - Energy augmentation structures for use with energy emitters and collectors (2024-04-23),

5. 11964166 - Energy augmentation structures, and their use in adhesive bonding (2024-04-23),

6. 11577092 - Phosphor-containing drug activator activatable by a monte carlo derived X-ray exposure, system containing the activator, and methods for use (2023-02-14),

7. 11305131 - X-ray psoralen activated cancer therapy (X-PACT) (2022-04-19),

8. 11260129 - Phosphor-containing drug activator, suspension thereof, system containing the suspension, and methods for use (2022-03-01),

9. 11207409 - X-RAY psoralen activated cancer therapy (X-PACT) with associated treatments (2021-12-28),

10. 11135294 - Methods for radiotherapy to trigger light activation drugs (2021-10-05),

11. 11077316 - Insertion devices and systems for production of emitted light internal to a medium and methods for their use (2021-08-03),

12. 10940329 - Phosphor-containing drug activator activatable by a Monte Carlo derived x-ray exposure, system containing the activator, and methods for use (2021-03-09),

13. 10596387 - Tumor imaging with X-rays and other high energy sources using as contrast agents photon-emitting phosphors having therapeutic properties (2020-03-24),

14. 10575541 - Phosphor composition having selected surface coatings (2020-03-03),

15. 10441810 - X-ray psoralen activated cancer therapy (X-PACT) (2019-10-15),

Title: Innovator Spotlight: Wayne F Beyer - Pioneering X-Ray Activated Drug Delivery

Introduction:

Wayne F Beyer, an esteemed inventor hailing from Bahama, NC, has made significant contributions to the field of medical innovation. With an impressive portfolio of 29 patents, Beyer continues to push the boundaries of science and technology.

Latest Patents:

1. Phosphor-containing Drug Activator Activatable by a Monte Carlo Derived X-ray Exposure: This patent showcases Beyer's groundbreaking work in creating a drug activator that can be activated by x-ray exposure for targeted treatment of diseased sites.

2. X-Ray Psoralen Activated Cancer Therapy (X-PACT): Another innovative patent by Beyer, this system offers a novel approach to treating diseased sites in the human or animal body by utilizing a combination of photoactivatable drugs and x-ray or high-energy electrons.

Career Highlights:

Beyer's dedication to innovation is evident in his collaborations with prominent companies such as Immunolight, LLC and Duke University. Through these partnerships, he has been able to translate his research into real-world applications that have the potential to revolutionize the field of medicine.

Collaborations:

During his career, Beyer has had the privilege of working alongside talented individuals such as Paul Theodore Hamilton and Harold Walder. These collaborations have been instrumental in shaping his innovative approach to medical technology and have led to the development of cutting-edge solutions for targeted drug delivery.

Conclusion:

Wayne F Beyer's contributions to the field of medical innovation are truly commendable. His pioneering work in x-ray activated drug delivery has the potential to transform the way we approach the treatment of various diseases. Beyer's relentless pursuit of excellence and his passion for pushing the boundaries of scientific discovery make him a standout figure in the world of inventors and innovators.